Current Hematologic Malignancy Reports- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details

About Current Hematologic Malignancy Reports

Current Hematologic Malignancy Reports is a journal published by Springer Science + Business Media. This journal covers the area[s] related to Cancer Research, Hematology, Oncology, etc. The coverage history of this journal is as follows: 2006-2022. The rank of this journal is 4868. This journal's impact score, h-index, and SJR are 2.98, 40, and 0.914, respectively. The ISSN of this journal is/are as follows: 15588211, 1558822X.

The best quartile of Current Hematologic Malignancy Reports is Q2. This journal has received a total of 556 citations during the last three years (Preceding 2022).

Current Hematologic Malignancy Reports Impact Score 2022-2023

The latest impact score (IS) of the Current Hematologic Malignancy Reports is 2.98. It is computed in the year 2023 as per its definition and based on Scopus data. 2.98

It is decreased by a factor of around 1.28, and the percentage change is -30.05% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Prediction of Current Hematologic Malignancy Reports Impact Score 2023

Impact Score 2022 of Current Hematologic Malignancy Reports is 2.98. If a similar downward trend continues, IS may decrease in 2023 as well.

Current Hematologic Malignancy Reports h-index

 

The h-index of Current Hematologic Malignancy Reports is 40. By definition of the h-index, this journal has at least 40 published articles with more than 40 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.

Current Hematologic Malignancy Reports ISSN

The International Standard Serial Number (ISSN) of Current Hematologic Malignancy Reports is/are as follows: 15588211, 1558822X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Current Hematologic Malignancy Reports Ranking and SCImago Journal Rank (SJR)

The Current Hematologic Malignancy Reports is ranked 4868 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.914.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Current Hematologic Malignancy Reports Publisher

The publisher of Current Hematologic Malignancy Reports is Springer Science + Business Media. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2006-2022.

Call For Papers (CFPs)

Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).

Abbreviation

The International Organization for Standardization 4 (ISO 4) abbreviation of Current Hematologic Malignancy Reports is Curr. Hematol. Malig. Rep.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Hematol. Malig. Rep.') can be used for citing, indexing, abstraction, and referencing purposes.

How to publish in Current Hematologic Malignancy Reports

If your area of research or discipline is related to Cancer Research, Hematology, Oncology, etc., please check the journal's official website to understand the complete publication process.

Acceptance Rate

There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

• Interest/demand of researchers/scientists for publishing in a specific journal/conference.
• The complexity of the peer review process and timeline.
• Time taken from draft submission to final publication.
• Number of submissions received and acceptance slots
• And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/
• Issn.org, https://www.issn.org/
• Scopus, https://www.scopus.com/